Abstract

The mannose-binding lectin associated-protease-3 (MASP-3) is a member of the lectin pathway of the complement system, a key component of human innate and active immunity. Mutations in MASP-3 have recently been found to be associated with Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome, a severe developmental disorder manifested by cleft palate, intellectual disability, and skeletal abnormalities. However, the molecular basis for MASP-3 function remains to be understood. Here we characterize the substrate specificity of MASP-3 by screening against a combinatorial peptide substrate library. Through this approach, we successfully identified a peptide substrate that was 20-fold more efficiently cleaved than any other identified to date. Furthermore, we demonstrated that mutant forms of the enzyme associated with 3MC syndrome were completely inactive against this substrate. To address the structural basis for this defect, we determined the 2.6-Å structure of the zymogen form of the G666E mutant of MASP-3. These data reveal that the mutation disrupts the active site and perturbs the position of the catalytic serine residue. Together, these insights into the function of MASP-3 reveal how a mutation in this enzyme causes it to be inactive and thus contribute to the 3MC syndrome.

Highlights

  • Mutants of the serine protease, mannose-binding lectin associated-protease-3 (MASP-3), are associated with Carnevale, Mingarelli, Malpuech and Michels (3MC) syndrome

  • The activity of M3Q against individual substrates derived from Rapid Endopeptidase Profiling Library (REPLi) library analysis (M[Abz]min؊1 M[E]؊1)

  • The activated (Fig. 1) mutant forms of mannose-binding lectin-associated serine proteases (MASPs)-3 associated with the 3MC syndrome were completely inactive against any substrate tested (Table 2)

Read more

Summary

Background

Mutants of the serine protease, mannose-binding lectin associated-protease-3 (MASP-3), are associated with Carnevale, Mingarelli, Malpuech and Michels (3MC) syndrome. To address the structural basis for this defect, we determined the 2.6-Å structure of the zymogen form of the G666E mutant of MASP-3 These data reveal that the mutation disrupts the active site and perturbs the position of the catalytic serine residue. In a previous study [20], we produced a form of human MASP-3 with a single Gln residue replacing the Lys residue N-terminal to the R-I activation bond (M3Q) This enzyme could be efficiently cleaved and activated by the C1r protease of the classical pathway complement [20]. We determined the 2.6-Å structure of the G666{197}E mutant protease in the zymogen form These data reveal substantial perturbation of the active site, consistent with a correlation between the lack of MASP-3 function and the 3MC syndrome

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call